Company Tagline
Providing Answers for Cancer Patients
Industry Category
Business Keywords
Company Description
Curasight is a leading biotechnology research company dedicated to providing innovative solutions for cancer patients. With a foundation built on over a decade of PET imaging research in cancer diseases at the University of Copenhagen and Rigshospitalet, Curasight is committed to advancing the field of cancer diagnostics and treatment monitoring.
Located at Ole Maaloes Vej 3, Copenhagen, Capital Region 2200, DK, Curasight focuses on the discovery and development of novel radiopharmaceuticals. These advancements aim to improve the diagnosis, risk stratification, and treatment monitoring of cancer diseases through PET imaging. Curasight's research program and academic collaborations are dedicated to identifying and developing disease-specific PET ligands for various cancer indications.
Curasight also strategically develops partnerships with larger pharmaceutical and biotechnology firms to enhance the ability to advance new PET ligands through late-stage clinical trials and bring them to market. Curasight is poised to make significant contributions to cancer care.
To the manager of Curasight, we invite you to create a customized and exclusive company showcase and product listing on our platform to further enhance your company's visibility and commercial development.
Curasight er en førende bioteknologisk forskningsvirksomhed, der er dedikeret til at levere innovative løsninger til kræftpatienter. Med et fundament bygget på over et årti med PET-billeddannelsesforskning i kræftsygdomme på Københavns Universitet og Rigshospitalet er Curasight forpligtet til at fremme området for kræftdiagnostik og behandlingsovervågning.
Beliggende på Ole Maaloes Vej 3, København, Hovedstadsområdet 2200, DK, fokuserer Curasight på opdagelse og udvikling af nye radiofarmaka. Disse fremskridt har til formål at forbedre diagnosticeringen, risikostratificeringen og behandlingsovervågningen af kræftsygdomme gennem PET-billeddannelse. Curasights forskningsprogram og akademiske samarbejder er dedikeret til at identificere og udvikle sygdomsspecifikke PET-ligander til forskellige kræftindikationer.
Curasight udvikler også strategisk partnerskaber med større farmaceutiske og bioteknologiske virksomheder for at forbedre evnen til at fremme nye PET-ligander gennem sene kliniske forsøg og bringe dem på markedet. Curasight er klar til at yde et væsentligt bidrag til kræftbehandling.
Til lederen af Curasight inviterer vi dig til at oprette en tilpasset og eksklusiv firmapræsentation og produktliste på vores platform for yderligere at forbedre din virksomheds synlighed og kommercielle udvikling.
Key Personnel / Employees
Similar Companies
Other organizations in the same industry
Alzamend Neuro
Biotechnology-ResearchTargeting treatment for Alzheimer's Disease, Major Depressive Disorder, Bipolar Disorder, and PTSD.
Mansfield Bio-Incubator
Biotechnology-ResearchA Collaborative Environment To Help Ensure Your Success
Entoprot Ltd
Biotechnology-ResearchTechnology for mass rearing of insects
Jornadas Andaluzas de Bioinformática #JABI2025
Biotechnology-Research*️⃣ ¡Ya está aquí la tercera edición! — JABI 2025 | 📆 12-14 de mayo, IHSM «La Mayora», Málaga https...
Alternative Company Names
This company is also known as